欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1707/001
药品名称
Everolimus Ethypharm
活性成分
everolimus 2.5 mg
剂型
Tablet
上市许可持有人
Ethypharm, France
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Austria (AT)
Denmark (DK)
Finland (FI)
Germany (DE)
Everolimus Ethypharm 2,5 mg Tabletten
United Kingdom (Northern Ireland) (XI)
Spain (ES)
Italy (IT)
Netherlands (NL)
Norway (NO)
Portugal (PT)
许可日期
2018/06/08
最近更新日期
2024/02/28
药物ATC编码
L01EG02 everolimus
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_1707_001_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_1707_001_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_1707_001_PAR
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase